Professionals Practice | Child, Adolescent, Adult Psychiatry

Practice – Related Information

Clinical Practice Center by the American Academy of Child and Adolescent Psychiatry
Centerwatch clinical trials information
Organizations and Meeting in psychiatry
Practice Management by the American Psychiatric Association
Practice Parameters by the American Academy of Child and Adolescent Psychiatry

Major Pediatric Psychopharmacological Trials

Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study.
The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation.
Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.
A 14-month randomized clinical trial of treatment strategies for attention–deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
3-year follow-up of the NIMH MTA study.
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHDin a multisite study.
Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
Predictors of parental accommodation in pediatric obsessive-compulsive disorder: findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) trial.
Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents withdepression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.
A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.
Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study.
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.